EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Immunosuppressive Adenosine Signaling: A Review of Potential Immunotherapy Combination Strategies

David Zahavi iD, James W Hodge iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24108871 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von David Zahavi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immuno-Oncology (CIO), Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 9000 Rockv…. Hauptthemen laut MEDLINE: Adenosine, Neoplasms. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment regulates many aspects of cancer progression and anti-tumor immunity. Cancer cells employ a variety of immunosuppressive mechanisms to dampen immune cell function in the tumor microenvironment. While immunotherapies that target these mechanisms, such as immune checkpoint blockade, have had notable clinical success, resistance is common, and there is an urgent need to identify additional targets. Extracellular adenosine, a metabolite of ATP, is found at high levels in the tumor microenvironment and has potent immunosuppressive properties. Targeting members of the adenosine signaling pathway represents a promising immunotherapeutic modality that can potentially synergize with conventional anti-cancer treatment strategies. In this review, we discuss the role of adenosine in cancer, present preclinical and clinical data on the efficacy adenosine pathway inhibition, and discuss possible combinatorial approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineNeoplasmsHumansImmunotherapyImmunosuppressive AgentsSignal TransductionTumor Microenvironment

Stichwörter der Autor:innen

adenosineclinical trialimmunotherapytreatment combination

Substanzen

AdenosineImmunosuppressive Agents

Autor:innen und Institutionen

  • Center for Immuno-Oncology (CIO), Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 9000 Rockville Pike, Bethesda, MD 20879, USA.

ORCID-Profile: David Zahavi, James W Hodge

Zitieren

APA

Zahavi, D., & Hodge, J. W. (2023). Targeting Immunosuppressive Adenosine Signaling: A Review of Potential Immunotherapy Combination Strategies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108871

Vancouver

Zahavi D, Hodge JW. Targeting Immunosuppressive Adenosine Signaling: A Review of Potential Immunotherapy Combination Strategies. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108871

BibTeX
@article{Zahavi2023,
  author = {Zahavi, David and Hodge, James W},
  title = {Targeting Immunosuppressive Adenosine Signaling: A Review of Potential Immunotherapy Combination Strategies},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24108871}
}
Kostenlos starten →